Inside Big Pharma’s Fight to Block Recreational Marijuana


Warning: A non-numeric value encountered in /home1/feminize/public_html/wp-content/plugins/socializer/socializer.php on line 411

It may come as a surprise to learn that pharmaceutical companies are fighting against legalization of recreational marijuana. This is not surprising at all, as the business model of pharmaceuticals depends on their ability to make money from the sale northern lights auto flower of prescription drugs, and weed would hurt their bottom line. Currently, cannabis remains a Schedule I drug, meaning it will not be regulated as an alternative medicine. As a result, Big Pharma is trying to stop legalizing recreational marijuana.

The pharmaceutical industry is worried about the budding marijuana industry. The legalization of medical marijuana in all fifty states could cost the industry an estimated $18.5 billion. Moreover, marijuana is a far safer alternative than many prescription drugs. Therefore, these corporations are opposed to the use of recreational cannabis. Despite the legalization of recreational marijuana, the pharmaceutical industry is fighting against this emerging industry, as they fear the disruption of their business model.

Insys is not the only pharmaceutical company to oppose legal marijuana. They put their profits before public health and opposed the initiative for corporate greed. The alcohol and tobacco industries are also anti-marijuana, as their products are more addictive and dangerous than marijuana. Nevertheless, their actions should not surprise anyone. These corporations are just one of many companies battling against marijuana. If legalization becomes a reality, they will have to make a choice.

Big pharma has a history of fighting against legalization of marijuana. In 2016, Insys Therapeutics made the largest personal campaign donation against a marijuana-legalization initiative in Arizona. These pharmaceutical firms have been a huge target for opponents of cannabis legalization in many states, including California. Their main concern is money, and they have a history of sacrificing patient welfare for profit. But if marijuana legalization does go ahead, they will continue to do everything they can to prevent it.

The pharmaceutical industry is an unethical industry. Its main motive is profit. The companies are willing to sacrifice patient welfare to protect their profits. And that’s exactly what they’re doing. They have become a major threat to the budding cannabis industry, and are working hard to stop it. They are already on their way to becoming a part of the marijuana business. They need to stop their naysaying campaign and start working for it.

Big pharma’s campaign to block legal marijuana in Arizona isn’t just about profits. The company has invested millions of dollars to fight the initiative in Arizona. Insys has a stake in the legalization of recreational marijuana in Arizona, and has backed the campaign. It is not the only company in the industry fighting to keep pot illegal. And it’s not just the legalization of recreational marijuana that is a concern.

The pharmaceutical industry has taken an active role in blocking legal marijuana. This is because of the high price of brand name drugs. Insys, a company that has a strong financial interest in marijuana, has backed the campaign. Its campaign was funded by the pharmaceutical company Insys, which recently received approval to develop synthetic marijuana. Using synthetic marijuana, it would cost a lot more to produce and manufacture.

The pharmaceutical industry’s lobbying efforts are primarily aimed at keeping pot illegal. Some companies have taken an active role in the campaign against marijuana, which is an effort to block the legalization of recreational marijuana. Some companies are even in the middle of a battle to keep pot illegal. They’re also actively trying to stop medical marijuana, which isn’t helping their sales. This is a losing proposition for both sides.

Some people might question this decision. It’s true that recreational marijuana has begun to bite into the sales of prescription drugs, but many pharmaceutical companies have stepped forward and taken a public role in keeping it illegal. As a result, the fight against recreational marijuana will not be over. As a matter of fact, it may be good for consumers and the environment. The pharmaceutical industry is already making huge profits from marijuana, and the drug industry is only getting more aggressive.